Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GD-iExo-001
- Development stage
- Phase 1
- Lead developer
- 3S Guojian Pharmaceutical
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intradermal
01
Overview
GD-iExo-001 is an investigational exosome-based biologic therapy derived from induced pluripotent stem cells (iPSCs). Developed by Beijing G-D Biotechnology in collaboration with Peking Union Medical College Hospital, it is designed to treat atopic dermatitis by leveraging the regenerative and immunomodulatory properties of iPSC-derived extracellular vesicles. These exosomes contain a complex cargo of proteins, microRNAs, and lipids that are hypothesized to suppress inflammatory cytokines and promote the restoration of the skin barrier. The therapy is administered via subcutaneous injection and is currently undergoing exploratory clinical evaluation to assess its safety, tolerability, and preliminary efficacy in patients with moderate-to-severe atopic dermatitis.
- Other names
- Induced Pluripotent Stem Cell Derived ExosomesiPSC-derived exosomes
Beyond the preview
Go deeper on GD-iExo-001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GD-iExo-001.